APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
Kopp, Jeffrey B; Nelson, George W; Sampath, Karmini; Johnson, Randall C; Genovese, Giulio; An, Ping; Friedman, David; Briggs, William; Dart, Richard; Korbet, Stephen; Mokrzycki, Michele H; Kimmel, Paul L; Limou, Sophie; Ahuja, Tejinder S; Berns, Jeffrey S; Fryc, Justyna; Simon, Eric E; Smith, Michael C; Trachtman, Howard; Michel, Donna M; Schelling, Jeffrey R; Vlahov, David; Pollak, Martin; Winkler, Cheryl A.
J Am Soc Nephrol
; 22(11): 2129-37, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21997394
APOL1 variants associate with increased risk of CKD among African Americans.
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
APOL1 and kidney disease.
Recent progress in HIV-associated nephropathy.
Impact of APOL1 polymorphism and IL-1ß priming in the entry and persistence of HIV-1 in human podocytes.
APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
Interventions for HIV-associated nephropathy.
APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle.
NPHS2 variation in sporadic focal segmental glomerulosclerosis.